{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:23:02Z","timestamp":1782231782881,"version":"3.54.5"},"reference-count":39,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":58,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Epileptic Disorders"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic><jats:bold>Objective.<\/jats:bold><\/jats:italic> To describe the clinical characteristics of cutaneous adverse reactions and cross\u2010sensitivity induced by antiseizure medications and compare the pattern of use of antiseizure medications in patients with epilepsy according to skin rash history.<\/jats:p><jats:p><jats:italic><jats:bold>Methods.<\/jats:bold><\/jats:italic> We analysed patients with a history of skin rash presenting for up to 12 weeks after initiating antiseizure medication. The history of skin rash was verified by medical charts, interviews, and identification of skin lesions by patients based on illustrative images. The minimum follow\u2010up period was eight months. The control group comprised epilepsy patients with regular antiseizure medication use for at least 12 weeks without skin rash. We included 109 cases and 99 controls.<\/jats:p><jats:p><jats:italic><jats:bold>Results.<\/jats:bold><\/jats:italic> The median (interquartile range) period from the index rash was six years (2\u201311). Carbamazepine was the trigger medication in 48% of cases and induced skin rashes in all patients with cross\u2010sensitivity and carbamazepine exposure. Stevens\u2010Johnson syndrome, toxic epidermal necrolysis, or drug reactions with eosinophilia and systemic symptoms affected 36% of cases. Carbamazepine\u2010 or oxcarbazepine\u2010induced maculopapular exanthema occurred earlier (median: one week) than that induced by other antiseizure medications (median: three weeks) (<jats:italic>p<\/jats:italic>=0.006). Cross\u2010sensitivity was more common in patients with at least one episode of Stevens\u2010Johnson syndrome (29%) and Stevens\u2010Johnson\/toxic epidermal necrolysis overlap (50%) than in patients with maculopapular exanthema (8%) (<jats:italic>p<\/jats:italic>=0.01). Although most cases were mild, the pattern of antiseizure medication use differed from that of controls, with a lower proportion of antiseizure medication typically associated with severe cutaneous adverse reactions (carbamazepine, phenytoin, phenobarbital, primidone, oxcarbazepine, and lamotrigine) (<jats:italic>p<\/jats:italic>&lt;0.001). Most cases exposed to high\u2010risk medication, however, did not develop cross\u2010sensitivity.<\/jats:p><jats:p><jats:italic><jats:bold>Significance.<\/jats:bold><\/jats:italic> Cutaneous adverse reaction history may influence antiseizure medication use. Cross\u2010sensitivity is more common in severe cases and most patients are affected by mild, self\u2010limited skin rashes. Further research should consider the relevance of mild skin rashes in lifelong epilepsy treatment.<\/jats:p>","DOI":"10.1684\/epd.2021.1288","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T13:07:43Z","timestamp":1626181663000},"page":"466-475","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment"],"prefix":"10.1002","volume":"23","author":[{"given":"Tallulah Spina","family":"Tensini","sequence":"first","affiliation":[{"name":"Neurology Department Federal University of Paran\u00e1 Curitiba Brazil"},{"name":"Pequeno Pr\u00edncipe School of Medicine Curitiba Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Q. C.","family":"Von Glehn","sequence":"additional","affiliation":[{"name":"Immunogenetics Laboratory Cajuru University Hospital Curitiba Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Bettinotti","sequence":"additional","affiliation":[{"name":"Immunogenetics Laboratory Johns Hopkins University School of Medicine USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Iglehart","sequence":"additional","affiliation":[{"name":"Immunogenetics Laboratory Johns Hopkins University School of Medicine USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"de Paola","sequence":"additional","affiliation":[{"name":"Neurology Department Federal University of Paran\u00e1 Curitiba Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Lohr","sequence":"additional","affiliation":[{"name":"Neuropediatrics Department Pequeno Pr\u00edncipe Hospital Curitiba Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Pediatric Critical Care Department Federal University of Paran\u00e1 Curitiba Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Spina","family":"Tensini","sequence":"additional","affiliation":[{"name":"Neurology Department Federal University of Paran\u00e1 Curitiba Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera L.","family":"Braatz","sequence":"additional","affiliation":[{"name":"Neurology Department Hospital S\u00e3o Jos\u00e9 Joinville Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E. S.","family":"Silvado","sequence":"additional","affiliation":[{"name":"Neurology Department Federal University of Paran\u00e1 Curitiba Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.0032"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13126"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3937"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14591"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000546"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000261917.83337.db"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701033"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07704.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.07.003"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2019.07.015"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13925"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100021880"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000334295.50403.4c"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2010.04.003"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000458725"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-019-00754-z"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(13)71015-6"},{"key":"e_1_2_7_20_1","unstructured":"Brazil Ministry of the Economy.Portal Brasileiro de Dados Abertos[Internet].2020[cited 2020 Oct 28]. Available from:https:\/\/dados.gov.br\/."},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X20130169"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1676-26492009000100009"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci200107b"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2008.07.086"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/es801845a"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0043-1354(98)00099-2"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25071639"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1897\/08-561.1"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5086503"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00423.x"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2008.04.003"},{"issue":"3","key":"e_1_2_7_32_1","first-page":"36","article-title":"Mild cutaneous reactions to drugs","volume":"90","author":"Crisafulli G.","year":"2019","journal-title":"Acta Biomed"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00130832-200410000-00013"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-015-0540-2"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000475802"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2015.08.006"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14704"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12347"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.061"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12074"}],"container-title":["Epileptic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1684\/epd.2021.1288","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T16:14:56Z","timestamp":1710778496000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1684\/epd.2021.1288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1684\/epd.2021.1288"],"URL":"https:\/\/doi.org\/10.1684\/epd.2021.1288","archive":["Portico"],"relation":{},"ISSN":["1294-9361","1950-6945"],"issn-type":[{"value":"1294-9361","type":"print"},{"value":"1950-6945","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"2020-09-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}